+ Follow DOHME Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1303704
[Title] => Dul-an 8 mil nahataga’g libreng HPV vaccine
[Summary] => Dul-an otso mil ka mga babayeng tinun-an ang nakakompleto na sa ilang libreng cervical cancer vaccine kagahapon dinhi sa dakbayan sa Sugbo. Ang libreng cervical cancer prevention vaccine mipahigayon og pagpamakuna sa 42 ka elementary schools kagahapon.
[DatePublished] => 2014-03-22 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Banat Balita
[SectionUrl] => balita
[URL] =>
)
[1] => Array
(
[ArticleID] => 425237
[Title] => What every woman should know
[Summary] => The Department of Health (DOH) alongside The Cancer Institute Foundation, The Cervical Cancer Prevention Network (CECAP), UP-PGH Obstetrics and Gynecology, Infectious Diseases Section (IDS), Immunizers, National Bookstore, Magnolia Healthy Drinks and Merck Sharp & Dohme (MSD) recently held a press conference entitled “Babae, Mahalaga Ka! Makiisa sa Laban, Magpa-Cervical Cancer Screening Na!” at the Hyatt Hotel.
[DatePublished] => 2008-12-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Allure
[SectionUrl] => allure
[URL] =>
)
[2] => Array
(
[ArticleID] => 354436
[Title] => Life-to-the-Max: Helping women fight osteoporosis
[Summary] => Facing the facts might be hard, but the truth of the matter is that the disease known as osteoporosis is a real threat to any woman of any age.
Causing bones to lose mass and become brittle, osteoporosis leads to painful fractures and often, the loss of height and rounded shoulders. Osteoporosis is a highly prevalent illness, affecting 75 million people worldwide. Prevention is key for those who are fortunate enough not to be suffering from it, but know that those who have osteoporosis need not sit back and let the disease take over.
[DatePublished] => 2006-08-24 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 226885
[Title] => Fortune magazine cites Merck & Co
[Summary] => Global research-based pharmaceutical company Merck & Co., Inc., which operates outside of the United States as Merck Sharp & Dohme (MSD), recently made it to Fortune magazine’s list of "Blue Ribbon Companies" – a recognition bestowed on companies that have made five or more of Fortune’s lists throughout the year.
[DatePublished] => 2003-11-06 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[4] => Array
(
[ArticleID] => 143606
[Title] => Latest evidence confirms:
Pain relief of rofecoxib in rheumatoid arthritis
[Summary] => The efficacy and potency of rofecoxib, an arthritis medicine was further confirmed by a broad range of studies presented at the recent American College of Rheumatology (ACR) in San Francisco, California. The new data presented showed that rofecoxib significantly reduced pain associated with rheumatoid arthritis (RA), one of the more serious and painful forms of arthritis. Rofecoxib is a product of Merck Sharp & Dohme (MSD), one of the world's leading pharmaceutical companies.
[DatePublished] => 2001-12-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
DOHME
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1303704
[Title] => Dul-an 8 mil nahataga’g libreng HPV vaccine
[Summary] => Dul-an otso mil ka mga babayeng tinun-an ang nakakompleto na sa ilang libreng cervical cancer vaccine kagahapon dinhi sa dakbayan sa Sugbo. Ang libreng cervical cancer prevention vaccine mipahigayon og pagpamakuna sa 42 ka elementary schools kagahapon.
[DatePublished] => 2014-03-22 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Banat Balita
[SectionUrl] => balita
[URL] =>
)
[1] => Array
(
[ArticleID] => 425237
[Title] => What every woman should know
[Summary] => The Department of Health (DOH) alongside The Cancer Institute Foundation, The Cervical Cancer Prevention Network (CECAP), UP-PGH Obstetrics and Gynecology, Infectious Diseases Section (IDS), Immunizers, National Bookstore, Magnolia Healthy Drinks and Merck Sharp & Dohme (MSD) recently held a press conference entitled “Babae, Mahalaga Ka! Makiisa sa Laban, Magpa-Cervical Cancer Screening Na!” at the Hyatt Hotel.
[DatePublished] => 2008-12-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Allure
[SectionUrl] => allure
[URL] =>
)
[2] => Array
(
[ArticleID] => 354436
[Title] => Life-to-the-Max: Helping women fight osteoporosis
[Summary] => Facing the facts might be hard, but the truth of the matter is that the disease known as osteoporosis is a real threat to any woman of any age.
Causing bones to lose mass and become brittle, osteoporosis leads to painful fractures and often, the loss of height and rounded shoulders. Osteoporosis is a highly prevalent illness, affecting 75 million people worldwide. Prevention is key for those who are fortunate enough not to be suffering from it, but know that those who have osteoporosis need not sit back and let the disease take over.
[DatePublished] => 2006-08-24 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 226885
[Title] => Fortune magazine cites Merck & Co
[Summary] => Global research-based pharmaceutical company Merck & Co., Inc., which operates outside of the United States as Merck Sharp & Dohme (MSD), recently made it to Fortune magazine’s list of "Blue Ribbon Companies" – a recognition bestowed on companies that have made five or more of Fortune’s lists throughout the year.
[DatePublished] => 2003-11-06 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[4] => Array
(
[ArticleID] => 143606
[Title] => Latest evidence confirms:
Pain relief of rofecoxib in rheumatoid arthritis
[Summary] => The efficacy and potency of rofecoxib, an arthritis medicine was further confirmed by a broad range of studies presented at the recent American College of Rheumatology (ACR) in San Francisco, California. The new data presented showed that rofecoxib significantly reduced pain associated with rheumatoid arthritis (RA), one of the more serious and painful forms of arthritis. Rofecoxib is a product of Merck Sharp & Dohme (MSD), one of the world's leading pharmaceutical companies.
[DatePublished] => 2001-12-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest
December 21, 2008 - 12:00am
August 24, 2006 - 12:00am
November 6, 2003 - 12:00am
December 14, 2001 - 12:00am
